GlassScriptPhysician profile
Mehran Farid-Moayer
NPI 1184690984
$664.93
in general payments reported to CMS, 2019-2025
18 companies · $22.97 in 2025
The $22.97 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $14.01 · 2021: $23.33 · 2023: $26.61 · 2024: $26.18 · 2025: $22.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $135.26 | 2019-2023 | |
| Glaxosmithkline, LLC. | $84.27 | 2019 | |
| Sunovion Pharmaceuticals INC. | $59.66 | 2019-2020 | |
| Mylan Specialty L.P. | $56.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $41.53 | 2019 | |
| Resmed Corp | $39.54 | 2019 | |
| Inspire Medical Systems, INC. | $26.18 | 2024 | Inspire |
| Advanced Respiratory, INC | $25.80 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.89 | 2019 | |
| Eisai INC. | $23.33 | 2021 | |
| Lilly USA, LLC | $22.97 | 2025 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $22.24 | 2019 | |
| Electromed, INC. | $20.01 | 2019 | |
| Genentech USA, INC. | $19.44 | 2019 | |
| Merck Sharp & Dohme LLC | $18.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $16.77 | 2019 | |
| Philips North America LLC | $14.52 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehran Farid-Moayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.